No operating activities or revenue in 2025 and 2024; 2025 net loss was $53,488 (2024: $52,494). Cash was $939 at December 31, 2025 (2024: $1,296); stockholders’ deficit widened to $307,913 (2024: $254,425). Total liabilities of $308,851 at year-end 2025 included $285,204 due to shareholders (interest-free, payable on demand). Shares outstanding: 64,990,254; number of holders: 175; aggregate market value of non‑affiliate equity: $1,183,826. Internal controls over financial reporting and disclosure controls were deemed not effective; material weaknesses include no audit committee, inadequate cash controls, and weak IT controls. Auditor issued an unqualified opinion with a going-concern emphasis due to accumulated deficit of $2,727,479 and continuing losses. Federal NOL carryforwards totaled approximately $2.72 million at 12/31/2025, fully offset by a valuation allowance. OTC trading range in 2025 showed high volatility; Q4 2025 high/low was $0.2414/$0.0029. Leadership change: Aziz Ali appointed Director, CEO, and CFO effective March 6, 2025; prior CEO/CFO resigned; their contingent compensation and warrants tied to a $75 million financing that did not occur were terminated. Strategy is to identify a merger/acquisition target; the majority shareholder indicates willingness to provide necessary financial support for at least the next 12 months.